XW033G6
XW033G6
is a valid billable ICD-10 procedure code for Introduction of REGN-COV2 Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 6.
It is found in the 2025 version of the ICD-10 Procedure Coding System (PCS) and can be used in all HIPAA-covered transactions from Oct 01, 2024 - Sep 30, 2025.
Introduction involves:
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
Percutaneous approach involves:
Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure
Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System device includes:
ICD-10-PCS code structure for XW033G6
— See Table View
1: Section | X |
New Technology |
---|---|---|
2: Body System | W |
Anatomical Regions |
3: Root Operation | 0 |
Introduction |
4: Body Part | 3 |
Peripheral Vein |
5: Approach | 3 |
Percutaneous |
6: Device | G |
Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System |
7: Qualifier | 6 |
New Technology Group 6 |
See also